InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,747.37
(
-0.95%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Sheep

Send PM Follow Ignore
Followers 114
Posts 6021
Boards Moderated 3
Alias Born 09/16/2009

Sheep

Re: $$$eeker post# 77426

Wednesday, 02/12/2014 4:58:23 PM

Wednesday, February 12, 2014 4:58:23 PM

Post# of 97239
DRRX I hate to see the wait on this. I know several were still in this.

FDA Says Additional Clinical Safety Studies Need to Be Conducted

http://finance.yahoo.com/news/durect-receives-complete-response-letter-214300646.html


DURECT is evaluating the issues described in the Complete Response Letter and plans to have further discussions with the FDA around them.



"In the coming months, we intend to work with the FDA to gain more clarity on the next steps that would be required to address the issues cited in the Complete Response Letter," stated James E. Brown, DVM, President and CEO of DURECT Corporation.

Email: sheepery@gmail.com

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up